XTL Biopharmaceuticals Ltd.

Regulatory Filings • Dec 1, 2014

_________ false

C001��� �� �� ������������� ��"�2PublicX T L BIOPHARMACEUTICALS LTD4313Corporation no: 520039470Stock Exchange/Market: -11996379Medinat hayehudim st 85 , Herzliya 4614001 , ,Tel: 09-9557080 , Fax: 09-9519727E.mail address: ir@xtlbio.comReported via MAGNA: 01/12/2014              Time of broadcast: 15:01 14:54:12

Company site:		www.xtlbio.com

Reference: 2014-02-211503

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Report of Periodic or Interim ReportRegulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
Financial results for the nine months period ended on September 30, 2014
XTL_Consolidated_FS_Q3-2014_6K_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure: 03/09/2014
- - -
Name of the Signatory: : Kntor Ronen , Position of Signatory in the reporting corporation: Legal Adviser , Name of Employer Company: .
Abba Hillel Silver Rd Telephone: 03-6133371 , Facsimile: 03-6133372 , E-mail: rkantor@kantor-law.com 2